GlassScriptPhysician profile
Samuel Kashani
NPI 1184821407
$58,943.13
in general payments reported to CMS, 2019-2025
41 companies · $14K in 2025
The $14K reported for 2025 was more than what 96% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $384 · 2020: $3,015 · 2021: $3,004 · 2022: $4,283 · 2023: $27K · 2024: $6,797 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $31K · Travel and Lodging: $4,485 · Food and Beverage: $4,225 · Education: $3,000 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,814 · Consulting Fee: $2,814.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $30,918.00 |
| Travel and Lodging | $4,485.05 |
| Food and Beverage | $4,225.25 |
| Education | $3,000.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,814.00 |
| Consulting Fee | $2,814.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $39,583.12 | 2023-2025 | Wakix |
| Intuitive Surgical, INC. | $8,750.44 | 2019-2023 | Davinci Xi, Da Vinci Surgical System |
| Tela Bio, INC. | $2,879.83 | 2019-2024 | Ovitex 2s |
| Davol INC. | $2,347.87 | 2024-2025 | Phasix Mesh, Bard 3dmax Mesh |
| Apollo Endosurgery US INC | $1,194.43 | 2022-2023 | Overstitch Endoscopic Suturing System |
| Medical Device Business Services, INC. | $916.89 | 2020 | |
| Smith+Nephew, INC. | $466.54 | 2019-2025 | Stravix, Collagenase Santyl, Stravix Pl |
| Medtronic, INC. | $426.37 | 2021-2025 | Transorb, Signia, Progrip |
| Baxter Healthcare | $365.70 | 2019-2024 | Perclot, Tisseel |
| Merz North America, INC. | $179.01 | 2022 | |
| Endo Pharmaceuticals INC. | $162.81 | 2019-2022 | |
| Integra Lifesciences Corporation | $156.59 | 2019-2024 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Innocoll Pharmaceuticals Limited | $127.29 | 2021-2022 | |
| Organogenesis INC. | $118.32 | 2021-2024 | Puraply |
| Biotissue Holdings INC. | $103.81 | 2024-2025 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Kashani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.